Moderna, Inc. (MRNA) › Shareholders' EquityModerna, Inc. (MRNA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$149.76M2016: -$334.81M2017: -$551.37M2018: $1.53B2019: $1.18B2020: $2.56B2021: $14.14B2022: $19.12B2023: $13.85B2024: $10.90B2025: $8.65B$8.65B2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$8.65B-20.6%2024$10.90B-21.3%2023$13.85B-27.6%2022$19.12B+35.2%2021$14.14B+452.3%2020$2.56B+118.0%2019$1.18B-23.2%2018$1.53B+377.5%2017-$551.37M-64.7%2016-$334.81M-123.6%2015-$149.76M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share